Sr. Staff Scientist, Cell Biology, Thermo Fisher Scientific
BIOGRAPHY
JUN 23, 2021 9:00 AM PDT
High titer adeno-associated virus (AAV) production that is Cost-effective and Scalable
Speaker
Event Date & Time
Date: June 23, 2021
Time: 9:00am PDT, 12:00pm EDT
Abstract
Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery method for the latest gene therapy breakthroughs. AAV has an efficacy and safety profile that makes it an ideal therapeutic vector—already part of several high-profile drug approvals in both the US and Europe. Yet, with this intensified interest in AAV therapies comes the need to scale-up viral production methods. As such, it’s imperative that successful viral production produce high titers that is cost-effective and scalable. During this webinar session, our presenter will highlight a scalable, high-titer, simplified AAV production in the AAV-MAX helper free AAV Production System.
Learning Objectives:
- Awareness of the Gibco AAV-MAX Helper-Free AAV Production System that is in the market and the upcoming launch of the RUO version
- Learn how to produce high titers with the Gibco AAV production system that allows for cost-effective scalability for AAV production.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...